Indolfi G; Hierro L; Dezsőfi, Antal; Jahnel J; Debray D; Hadzic N; Czubowski P; Gupte G; Mozer-Glassberg Y; van der Woerd W; Smets F; Verkade HJ; Fischler B
(2018)
Objectives: In 2017, the European Medicines Agency and the Food and Drug Administration approved the use of the fixed-dose combination of ledipasvir/sofosbuvir and of the combination of sofosbuvir and ribavirin for treatment ...